What is the recommended dosage of Nitrofurantoin (Macrobid) for treating uncomplicated urinary tract infections (UTIs)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Nitrofurantoin Dosing for Uncomplicated UTI

The recommended dosage of nitrofurantoin monohydrate/macrocrystals (Macrobid) for treating uncomplicated urinary tract infections is 100 mg twice daily for 5 days. 1, 2, 3

First-Line Treatment Recommendation

  • Nitrofurantoin is recommended as a first-line agent for uncomplicated UTIs by both the Infectious Diseases Society of America (IDSA) and the European Association of Urology due to its high efficacy and low resistance rates 1, 3
  • Clinical cure rates with nitrofurantoin range from 88-93% for uncomplicated UTIs in women 1
  • Bacterial cure rates range from 81-92% for uncomplicated UTIs in women 1

Dosing Specifics

  • The standard formulation used is nitrofurantoin monohydrate/macrocrystals (Macrobid) at 100 mg twice daily 1, 2
  • The recommended duration is 5 days for uncomplicated UTIs in women 1, 2
  • Alternative formulation: nitrofurantoin macrocrystals can be used at a dose of 50-100 mg four times daily for 5 days 1

Important Contraindications

  • Nitrofurantoin is contraindicated in patients with creatinine clearance <60 mL/min due to:
    • Inadequate urinary drug concentrations that would prevent bactericidal activity 3
    • Increased risk of toxicity, including peripheral neuropathy 2
  • Nitrofurantoin should be avoided if early pyelonephritis is suspected 1

Alternative First-Line Options

When nitrofurantoin cannot be used, consider:

  • Fosfomycin trometamol 3 g single dose (slightly lower efficacy than nitrofurantoin) 1
  • Trimethoprim-sulfamethoxazole 160/800 mg twice daily for 3 days (only if local resistance rates <20% or if the infecting strain is confirmed susceptible) 1, 2
  • For patients with renal impairment (CrCl <60 mL/min), consider trimethoprim-sulfamethoxazole or fosfomycin trometamol as alternatives 2

Efficacy Comparison

  • The 5-day regimen of nitrofurantoin (100 mg twice daily) has been shown to be equivalent to trimethoprim-sulfamethoxazole (160/800 mg twice daily for 3 days) in clinical and microbiological cure rates 1, 4
  • Nitrofurantoin has similar clinical cure rates to ciprofloxacin and trimethoprim-sulfamethoxazole when comparing 7-day regimens 1

Common Side Effects and Monitoring

  • Most common side effects include nausea and headache 1
  • Adverse event rates range from 5.6-34% across studies 1
  • Headache occurs in approximately 10.8% of patients 5
  • Monitor for signs of toxicity in patients with borderline renal function, including peripheral neuropathy, pulmonary reactions, and hepatotoxicity 2

Follow-up Recommendations

  • Routine post-treatment urinalysis or urine cultures are not indicated for asymptomatic patients 1
  • For women whose symptoms do not resolve by the end of treatment or recur within 2 weeks, obtain a urine culture with susceptibility testing 1
  • Consider retreatment with a 7-day regimen using another agent if symptoms persist or recur 1

References

Guideline

Nitrofurantoin Dosing for Uncomplicated UTI

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Nitrofurantoin Dosing Considerations in Adults with UTIs

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Nitrofurantoin Clinical Efficacy and Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.